Recruiting AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases. NCT06991114 Conditions Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +29 more Locations Artiva Investigational Site Tuscaloosa — Tuscaloosa, Alabama, United States Artiva Investigational Site Phoenix — Phoenix, Arizona, United States Artiva Investigational Site Tucson — Tucson, Arizona, United States Artiva Investigational Site Chula Vista — Chula Vista, California, United States View all 52 locations View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases NCT06775912 Conditions ANCA Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +16 more Locations The First People's Hospital of Lianyungang — Lianyungang, Jiangus, China View Trial Details
Recruiting MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) NCT07374107 Conditions Anti-synthetase Syndrome, Behavior, Connective Tissue Diseases, +26 more Locations MIHRA Foundation - This is a GLOBAL STUDY — New Orleans, Louisiana, United States View Trial Details
Recruiting A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. NCT07203404 Conditions ANCA Associated Vasculitis, ANCA-Associated Glomerulonephritis, Anti-GBM Disease, +27 more Locations Bioheng Study site — Shanghai, China View Trial Details
